Position in ALEC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$217,853
+$58,849 QoQ
Shares Held
101,327
-0.6% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. ALEC ranks #199 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ALEC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,853 | 101,327 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $159,004 | 101,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $338,239 | 114,270 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $177,195 | 126,568 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $143,461 | 116,635 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $219,041 | 115,895 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $531,258 | 114,004 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $499,054 | 109,924 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $550,986 | 91,526 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $699,032 | 87,598 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $568,172 | 87,681 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $544,584 | 90,613 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $512,730 | 82,832 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $768,877 | 83,302 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $747,983 | 79,068 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $765,108 | 75,306 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $875,976 | 61,472 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,233,197 | 59,719 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,383,462 | 60,625 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,209,743 | 58,077 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,124,436 | 55,831 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $905,258 | 59,832 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $600,621 | 57,012 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,624,209 | 66,457 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,057,690 | 43,833 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||